ArticleJournal of clinical laboratory analysis2020

Utilizing CRISPR/Cas9 technology to prepare lymphoblastoid cell lines harboring genetic mutations for generating quality control materials in genetic testing.

Li Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.